Practical Issues in Managing Systemic Inflammatory Disorders During the COVID-19 Pandemic

Area of Science:

• Rheumatology and Immunology
• Infectious Diseases
• Health Services Research

Background:

• The COVID-19 pandemic poses significant risks to patients with systemic inflammatory disorders due to their compromised immune status and comorbidities.
• Maintaining optimal management of rheumatic diseases during the pandemic is crucial to prevent disease flares and associated complications.
• Physical distancing measures complicate traditional in-person patient assessment and monitoring.

Purpose of the Study:

• To discuss the challenges in assessing and monitoring patients with systemic inflammatory diseases during the COVID-19 pandemic.
• To explore solutions for the prescription and supply of anti-rheumatic drugs amidst public health restrictions.
• To examine the potential of e-health and technological tools in managing these patients remotely.

Main Methods:

• Literature review and expert discussion on the impact of COVID-19 on systemic inflammatory diseases.
• Analysis of challenges in patient monitoring and drug management.
• Exploration of technological solutions, including telemedicine and wireless tools.

Main Results:

• Systemic inflammatory disease patients face heightened infection risk and management complexities during the pandemic.
• Disruptions in drug supply chains and patient access to care are significant concerns.
• E-health solutions offer promising avenues for remote patient assessment, monitoring, and treatment adherence.

Conclusions:

• The pandemic necessitates adaptive strategies for managing systemic inflammatory diseases, emphasizing remote care.
• Leveraging e-health can improve clinical care standards and reduce healthcare system burden post-pandemic.
• Technological integration is vital for resilient healthcare systems supporting vulnerable patient populations.